ClinicalTrials.gg
RecruitingNCT07925528Updated Nov 9, 2026

Neodymium Magnet-Guided Removal of Metallic Soft Tissue Foreign Bodies in the Emergency Department

An interventional study of Neodymium magnet-guided foreign body removal in Foreign Bodies, Soft Tissue Foreign Body and Wounds, Penetrating, sponsored by Uludag University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Uludag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Dec 2025, registered Nov 2026).
  • Started Dec 2025; still recruiting 11 months later.
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a strong magnet (neodymium magnet) can help doctors remove metal objects stuck under the skin in adults. It will also learn about the safety of this method. The main questions it aims to answer are:

  • How often can doctors remove the metal object with the help of the magnet?
  • How long does the procedure take?
  • How often do doctors need to make a cut in the skin, and how long is the cut?
  • What problems do participants have within 15 days after the procedure?
  • How satisfied are participants with the procedure?

Participants will:

  • Have an X-ray to find the metal object
  • Have the metal object removed with the help of the magnet in the emergency department, with or without numbing medicine (local anesthetic)
  • Come back for a wound check 15 days after the procedure
Read the detailed description

This prospective, single-center, single-arm study is conducted in the Emergency Department of Bursa Uludag University Faculty of Medicine Hospital. Before the procedure, the location of the foreign body and its distance from the skin surface are measured on X-ray, and the entry site is photographed. Before sterile preparation, the magnetic property of the foreign body is confirmed with the neodymium magnet. After sterile preparation, the foreign body is localized with a sterile-draped neodymium magnet. Local anesthesia is applied if needed. The foreign body is removed through the existing wound or, if there is none, through a skin incision. The site is photographed again after removal. Prophylactic antibiotics are given for contaminated wounds. Participants are re-evaluated at suture removal or 15 days after the procedure.

02

Conditions studied

  • Foreign Bodies
  • Soft Tissue Foreign Body
  • Wounds, Penetrating

Keywords

  • Neodymium magnet
  • NdFeB magnet
  • Rare earth magnet
  • Metallic foreign body
  • Foreign body removal
  • Emergency department
03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

Browse Foreign Bodies studies →

Lead sponsor

Uludag University is the lead sponsor of 149 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Metallic foreign body in the soft tissue detected on plain radiography
  • Foreign body located less than 2 cm from the skin surface
  • Foreign body with magnetic properties that interacts with the magnet
  • Signed written

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Foreign body located close to structures such as blood vessels, nerves or joint spaces
  • Deep location requiring surgical removal
  • Inability to cooperate
  • Bleeding or coagulation disorder
  • Refusal to sign
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Neodymium Magnet-Guided Removal

    Adults with a magnetic metallic foreign body in the soft tissue. The foreign body is removed with the help of a neodymium magnet in the emergency department, with or without local anesthesia.

    Procedure: Neodymium magnet-guided foreign body removal

Interventions

  • ProcedureNeodymium magnet-guided foreign body removal

    After sterile preparation, the foreign body is localized and pulled toward the skin surface with a sterile-draped neodymium (NdFeB) magnet, and removed through the existing wound or a skin incision.

    Also known as: Rare earth magnet

06

What researchers measure

Primary outcomes

  1. Successful removal of the foreign body

    Number and percentage of foreign bodies successfully removed with the help of the neodymium magnet.

    Time frame: During the procedure (Day 0)

Secondary outcomes

  1. Complete removal per participant

    Number and percentage of participants in whom all foreign bodies were successfully removed.

    Time frame: During the procedure (Day 0)

  2. Procedure time

    Duration of the foreign body removal procedure, in minutes.

    Time frame: During the procedure (Day 0)

  3. Need for additional incision and its length

    Number and percentage of participants who need a new or additional skin incision, and the length of the incision in millimeters, if required.

    Time frame: During the procedure (Day 0)

  4. Volume of local anesthetic

    Volume of local anesthetic used during the procedure, in milliliters, in participants who receive local anesthesia.

    Time frame: During the procedure (Day 0)

  5. Complications

    Number and percentage of participants with complications (such as wound infection or bleeding) within 15 days after the procedure.

    Time frame: 15 days after the procedure

  6. Patient satisfaction

    Participant satisfaction with the procedure on a 5-point Likert scale (1 = not satisfied at all, 5 = very satisfied). Higher scores mean greater satisfaction.

    Time frame: Immediately after the procedure (Day 0)

07

Study locations

1 of 1 sites recruiting
  • Bursa Uludag University Faculty of Medicine Hospital, Emergency Department
    Bursa, Bursa 16059, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Shvediuk VV, Elin NE, Dzidzava II, Fufayev EE, Barinov OV. Clinical application of neodymium magnetic instruments for the removal of foreign bodies in blind wounds. Russian Military Medical Academy Reports. 2023;42(2):105-114. doi: 10.17816/rmmar346674.
  • Sarihan A, Can C. Soft tissue foreign body removal with magnet in ED settings. Am J Emerg Med. 2014 Aug;32(8):952.e3-5. doi: 10.1016/j.ajem.2014.02.009. Epub 2014 Feb 17. No abstract available. PubMed 24657226 ↗
  • Radia R, Suffern R, Pepper T, Fan K. A blacksmith's tale: use of a rare earth magnet to facilitate safe removal of a metallic fragment from the face. Br J Oral Maxillofac Surg. 2020 Dec;58(10):e317-e319. doi: 10.1016/j.bjoms.2020.07.029. Epub 2020 Jul 26. PubMed 32807596 ↗
  • Lukish JT, Williams K, Shah A, Mon R, Lukish JR. The Novel Use of Rare Earth Magnets for the Extraction of Metallic Soft Tissue Foreign Bodies in Children. Surg Innov. 2023 Oct;30(5):571-575. doi: 10.1177/15533506231158209. Epub 2023 Mar 14. PubMed 36916247 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared because the informed consent form and ethics approval do not cover sharing of individual-level data with third parties. Aggregated results will be published.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2025 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Dec 9, 2025
Primary completionEst.
Jan 5, 2027
CompletionEst.
Jan 5, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925528
Lead sponsor
Uludag University
Responsible party
Ziya Uzun (Lecturer, MD, Uludag University) — Principal investigator
First posted
Nov 9, 2026
Start date
Dec 9, 2025
Primary completion
Jan 5, 2027 (estimated)
Completion
Jan 5, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Ziya Uzun, MD
Contact
ziyauzun@uludag.edu.tr
+90 538 737 96 52
Ziya Uzun, MD
principal investigator · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion